Not exact matches
Researchers have developed a new
cognitive test that can better determine whether memory
impairments are
due to very
mild Alzheimer's disease or the normal aging process.
The operationalization of
mild cognitive impairment (MCI) led to targeting earlier symptomatic cases of the illness and treatment strategies based less on pathology and more on a chance to halt or slow decline than there would be earlier in the disease.1 With the development of amyloid imaging, MCI
due to AD diagnosis was refined, 2 and early - stage AD was extended further to include preclinical AD, 3 wherein a positive amyloid positron emission tomography (PET) scan or diagnostic low levels of cerebrospinal fluid β - amyloid (Aβ) indicated the presence of pathology in people who were cognitively normal.
The study focused on participants having
mild cognitive impairment,
due to the fact many were most likely going to develop Alzheimer's disease in just a few years.
In addition, the 25 percent of the participants who had
mild cognitive impairment associated with Alzheimer's also experienced an increase in brain volume
due to the higher amounts of exercise.